Globalization and multidrug resistance are amongst the factors implicated in the resurgence of infectious diseases in recent years. This has fostered a compelling need in drug discovery to replace (or supplement) existing schedules. The floral biodiversity has been identified as a viable resource platform due to its inimitable chemical characteristics as well as the presence of numerous of its members in traditional medicinal approaches towards these diseases. Whilst the plant family Amaryllidaceae is conventionally associated with cancer and motor-neuron disease therapies, this survey shows that it has a significant presence in the remediation of infections and infection-related ailments. This verifiable indigenous knowledge could amplify efforts towards the identification of the active chemical constituents.
Infectious diseases have had a long and intimate association with both the plant and animal kingdoms along the course of evolution [1a,b] . History is replete with references to the devastation wrought upon whole communities and populations by these diseases including, 'plague', 'Spanish flu', 'SARS', 'bird flu' and 'ebola' [2a-c] . Over the past century, the advent of organized healthcare structures, as well as improved nutrition and medicine, has served to minimize the burden of these diseases [1b] . However, with the increasing use of antibiotics the epidemiological outlook is bleak as gauged by the widespread re-emergence of infectious diseases primarily as a consequence of multidrug-resistance [1b] . Given these facts, infectious (or communicable) diseases are designated priority status diseases in prevention and control measures implemented by the World Health Organization (WHO) [3a] .
Prior to the dispensation of the antibiotic, mankind depended largely on good health and nutrition to overcome the burden of disease [1a,b] . However, much of his medicinal needs were invariably met by the abundance of medicinal herbs foraged from his immediate surroundings [3b] . Today, our reliance on antibiotics has advanced to such an extent that the use of plant products as antimicrobials in the clinical setup is virtually non-existent [3c]. However, this trend is expected to see a downturn owing to multidrug-resistance and the fact that antibiotics have a limited lifespan [3c] . The global natural floral abundance, in which it is estimated that less than 20% of known plants have been examined for potential therapeutic benefits, affords a vast array of structural diversity from which several candidates have already been identified with significant promise as future antimicrobial chemotherapeutics [3c].
The plant family Amaryllidaceae J.St.-Hil. is one of the most recognizable bulbous plant families known worldwide for its esthetic floral characteristics, its exploitation in traditional medicine (TM) as well as its unique bioactive alkaloid constituents [4a-g] . It has experienced considerable success commercially owing to the potencies of its galanthamine representatives as Alzheimer's drug chemotherapeutics [5a-b] . Future successes are believed to reside with other of its alkaloid principles as anticancer agents due to their potent and selective cytotoxic activities [6a-g] . In spite of these specific pharmaceutical applications, the Amaryllidaceae is known to be used in twenty-five different countries around the globe for infections and infection-related ailments. This survey seeks to highlight the forty-eight species of the family identified in the ethnopharmacological literature for their specific use in such instances.
Although the Amaryllidaceae has a pantropical distribution its members are prominent within three geographical locations around the globe, these being Andean South America, the Mediterranean basin and South Africa [7] . Over a third of the approximately 1000 known species are found in South Africa, mostly within the winter rainfall region of the Western Cape Province [7] . Given this floral abundance, as well as the rich cultural heritage of South Africa [8, 9] , not surprisingly, the majority of Amaryllidaceae plants used in TM for infection-related conditions are found in this area (Table  1) . Apart from this, ethnic usage of the Amaryllidaceae for such purposes was seen to encompass twenty-four other countries. Africa and Asia had the largest numerical representation with eight member states each (32%). However, the former reported usage of twenty-nine species (60.4%) of the Amaryllidaceae for infectious ailments compared with eleven (22.9%) for the latter. Special mention should also be made of the DRC, which with three representatives was behind only India and South Africa in terms of species used. Interestingly, these were all seen to belong to the genus Crinum including, C. giganteum, C. scabrum and C. zeylanicum [8,10a,b] . This was followed closely by Cameroon, Nigeria and Sudan, each with two representative species (Table 1) . Nineteen (39.6%) out of the forty-eight species recorded in the ethnopharmacological literature for infection purposes occur over the southern African region [4a,f,8,9,10a] . Out of these Crinum and Haemanthus, with five and four species, respectively, were the most represented genera [4a,f,8,9,10a] . Not surprisingly, the family Amaryllidaceae finds extensive usage in the traditional remediation of infectious conditions in the southern African region where around thirty such instances (Table 1) were discernible in the literature [4a,f,8,9,10a] .
The Andes and Mediterranean regions, where there is conventionally a significant proliferation of Amaryllidaceae species, were surprisingly only represented by Peru (Eustephia coccinea), Argentina (Hippeastrum parodii and Zephyranthes carinata), Turkey (Narcissus tazetta) and Bulgaria (Galanthus nivalis and Leucojum aestivum) [4b,5b,11a-c] . For the former region, it can be argued that these plants may have greater representation than indicated in Andean medicinal traditions but that this usage is still to find its way into the scientific literature. For the latter, it is understandable that traditional medicine has largely been overshadowed by the dominance of First World medicinal practices. Crinum was the most utilized genus with twenty of its species (37.5%) listed from eighteen different countries as applicable to infectious conditions (Table 1) . Furthermore, C. asiaticum was the most widely-used Amaryllidaceae plant with listings from six nations which included, Bangladesh, India, Indonesia, Myanmar, South Pacific and Thailand [10a,12a-b] . Overall, Boophone disticha had the largest number (ten) of individual category listings pertaining to infections, followed by Crinum bulbispermum (nine) and C. asiaticum (eight) [8,10a,12b,13] . Of the South African contingent, Boophone disticha, Brunsvigia grandiflora and Crinum bulbispermum had the widest applicability when it came to treating infections in the region [4a,8,9,13,14a-e] . In this regard, eighteen (64.3%) of the twentyeight listings for usage of the South African Amaryllidaceae for infections can be traced to these three plants (Table 1) .
Although not endowed with a wide variety of Amaryllidaceae species, India was second to South Africa in its exploitation of the family to treat these ailments in TM (Table 1) . These included four Crinum species (C. asiaticum, C. bulbispermum, C. latifolium and C. pratense) from the region as well as Haemanthus kalbreyeri and Zephyranthes flava [8,6a,10a,12b,15] . From this, eleven specific areas were identified which were of relevance in the remediation of infectious conditions [8,6a,10a,12b,15] . Of the remaining seven Asian countries, China and Indonesia each had two representatives [12a,16a-c] . Intriguingly, the two countries of the Americas (Dominican Republic and Haiti) both used Crinum species (C. zeylanicum and C. erubescens, respectively) in the treatment of malaria [10a] . Finally, both listings from the South Pacific were also in relation to Crinum species (C. asiaticum and C. macrantherum), in this instance for the treatment of wounds [10a,12b] .
The use of Amaryllidaceae plants for infection-related purposes as shown in Table 1 is extensive, ranging from common colds and fever to life-threatening illnesses such as malaria and TB. In relation to plant parts used, although roots, leaves and flowers were mentioned in several instances, bulbs were the predominant feature in preparations used around the world. Interestingly, three of the five occasions where root preparations were administered (Clivia miniata, Crinum asiaticum and Haemanthus kalbreyeri) were all pertinent to treatment of colds and fever [4a,8,12b,15] . For the two instances that flower concoctions were applicable, these related to usage for coughs, colds and wounds (H. kalbreyeri), as well as dysentery (N. tazetta) [4b,15] . The use of leaf material to treat diverse ailments in various countries was restricted to the four plants, Crinum asiaticum, C. bulbispermum, C. purpurascens and Haemanthus coccineus [8,9,10a,12b,17] . Interestingly, leaf extracts of C. asiaticum alone were shown to be utilized in four different areas; India, Myanmar, the South Pacific and Thailand [12b].
Seven plants (Clivia miniata, Crinum asiaticum, C. bulbispermum, C. macowanii, Galanthus nivalis, Leucojum aestivum and Scadoxus puniceus) were shown to be used for fever, which is assumed to be in reference to viral infections [4a,5b,8,9,10a,12a,b,14e,18a-d] . Furthermore, Zephyramthes flava has been highlighted for its specific use for viral infections [6a] , whilst Galanthus nivalis, G. woronowii and Leucojum aestivum are known as herbal remedies for poliomyelitis [5a-b] . In addition, leaf decoctions of Crinum asiaticum are used in Myanmar for the treatment of herpes [12b].
In relation to bacterial pathogenesis, there are two instances in the literature that Amaryllidaceae plants are mentioned specifically for microbial purposes. These involve Crinum purpurascens and Scadoxus pseudocaulus, both emanating from work carried out in Cameroon [17, 19] . Twelve plants from around the world, Ammocharis coranica, Boophone disticha, Crinum asiaticum, C. bulbispermum, C. jagus, C. kirkii, C. macrantherum, C. macowanii, Cyrtanthus obliquus, Haemanthus coccineus, H. kalbreyeri and Narcissus tazetta, were shown to be used for sores, wounds and boils [4a,b,8,9,10a,12b,13,14a,14e,15,18a,b,20a-f] . Noticeably, such use was a common theme in the TM of the four most populous indigenous tribes in South Africa; the Sotho, Tswana, Xhosa and Zulu people [4a,4f,8,9] . Bulb concoctions of Crinum macowanii, C. moorei, Cyrtanthus obliquus and Gethyllis namaquensis were shown to be effective for sexually-transmitted and venereal diseases from bacterial vectors such as Chlamydia trachomatis and Neisseria gonorrhoeae in South Africa and Zimbabwe, respectively [9,10a,18a,20d,20g,h] . Further use of these plants for ailments arising out of bacterial pathogenesis pertained to the treatment of diarrhea where bulb infusions of Brunsvigia grandiflora and Crinum pratense were shown to be useful [10a,14b] .
In relation to mycobacterial pathogenesis, Crinum giganteum, C. scabrum, Cyrtanthus elatus and C. obliquus are used in the traditional remediation of leprosy, the first two in the DRC and the latter two in South Africa [8,10a,20c,21a] . Also in this regard, six plants were indicated for the treatment of tuberculosis (TB), Boophone disticha, Brunsvigia grandiflora, Cyrtanthus obliquus, Scadoxus puniceus, Crinum glaucum and C. jagus, the first four of which occur in South Africa whilst the remaining two are Nigerian medicinal plants [8,9,13,14c,d,18d,21b,c] . Interestingly, South Africa is widely recognized as the epicentre of the prevailing TB epidemic which has been exacerbated largely by the high incidence of HIV-AIDS [14c,d] . It is also noteworthy that the remaining two plants Crinum glaucum and C. jagus, which are Nigerian taxa have their origin in an area also known for high TB prevalence [21b,c]. Also striking is the use of Cyrtanthus obliquus in South Africa for both of these mycobacterial diseases i.e. leprosy and TB [8,20c] .
Little is known about the use of Amaryllidaceae plants in the treatment of fungal infections, so that the mention of Eustephia coccinea specifically for such purposes in the Andean Peru region is symbolic [11a,b] . Furthermore, since Crinum macowanii, C. moorei, Cyrtanthus obliquus and Gethyllis namaquensis, as mentioned above, have been singled out for their usage against STDs [9,10a,18a,20d,20g,h] , it can be construed that they may inadvertently also be active against sexually-transmitted fungal pathogens such as Candida albicans.
The use of these plants for parasitic diseases was mentioned on four separate occasions in the literature including, findings from Argentina , Madagascar and the DRC [10b,11c,22a ]. In particular, [8,9] [4a,8,9,13] [ 8,9] [8,9,13] the seven Amaryllidaceae plants Boophone disticha, Crinum x amabile, C. bulbispermum, C. erubescens, C. macowanii, C. zeylanicum and Pamianthe peruviana have been recorded as applicable to the treatment of malaria [8,9,10a, 13,22b-d] .
In summary, the plant family Amaryllidaceae is significantly represented in the ethnopharmacological literature through its usage in the treatment of infection-related ailments. Although a relatively small proportion (<5%) of its global complement of species can be accounted for in this niche area, it has nevertheless made a strong showing in areas such as Africa where there is conventionally a rich culture of traditional medicine. In particular, the southern African region has afforded the largest number of species which have demonstrated their utility for these purposes. The diverse uses demonstrated in TM suggests that these plants are effective within a broad microbial window incorporating bacterial, fungal, parasitic and viral pathogenesis. Although significant resources have in instances been chanelled towards the pharmacological validation of these plant uses, further sustained efforts are required in the identification of their active principles.
